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ABSTRACT  
Objective: The present study was carried out to evaluate the combined cardioprotective effect of standardized extract of Tinospora 
cordifolia extract (TCE) with atenolol (AT) and propranolol (PP) in isoproterenol (ISO) induced cardiac necrosis in rats.  
Methods: Myocardial infarction (MI) or cardiac necrosis was induced by subcutaneous administration of ISO for two days consecutively at an interval of 
24 h. Rats were pre-administered with test drugs for 21 d followed by ISO was administration on 20 and 21st day. 24 h after final ISO administration, 
mean arterial blood pressure (MAB), Heart rate (HR), electrocardiogram (ECG), heart bio-marker enzyme, and histopathological study of cardiac tissue 
were evaluated from control and experimental groups and analyzed statistically by one-way ANOVA followed by Tukeys’s test.  
Results: Rats administered with ISO showed significant (p<0.001) changes in ECG, HR, MAB, heart bio-marker enzyme, antioxidant parameters, and 
histopathology of the heart. The activities of biomarkers have reduced in serum and there is a significant (p<0.001) increase in antioxidants in the 
heart tissue of animals treated with drug combination. Similarly, ECG, MAB, and HR were restored to normalcy in drug-treated animals.  
Conclusion: It may be concluded that the herb-drug combinations i. e TCE (500 mg/kg)+AT (10 mg/kg) and TCE (500 mg/kg)+PP (10 mg/kg) has 
shown increased cardioprotective activity than they were used alone. 
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INTRODUCTION
Currently, cardiovascular diseases are major contributors to the high 
incidence of mortality occurring globally. Hence, there is a need for 
extensive research for the effective treatment of these cardiovascular 
diseases. For the experiment on cardiac tissue necrosis, often 
chemical-induced animal models are preferred, and a β receptor 
agonist such as ISO is used widely to screen the cardio-protective 
effect of different test drugs. Severe oxidative stress is caused by ISO in 
the myocardial cells, and at increased doses, it produces MI-like 
changes in the heart tissue [1]. It is a well-known fact that the ISO-
generated free radicals initiate the lipid peroxidation of membrane-
bound polyunsaturated fatty acids, which leads to structural as well as 
functional cardiac tissue injury [2, 3].  
  
Tinospora cordifolia (Menispermaceae) is reported in scientific literature 
as a constituent of many active compound formulations used in the 
treatment of general diseases like dyspepsia, fever, and urinary diseases. 
In the Ayurvedic literature, Tinospora cordifolia (Amrita) is mentioned in 
various classical texts, like Sushrut samhita, Charak samhita, and Ashtang 
Hridaya and other treaties like Dhanvantari Nighantu, and Bhava 
Prakash under other synonyms such as Amritvalli, Chinnodebha, Amara, 
Vatsadani, and Chinnarrhuha, etc [4]. Conventional medicines like 
atenolol, propranolol which are β blockers, are very often prescribed in 
the treatment of hypertension, angina pectoris, and arrhythmias [5]. 
However, on the combined effects of a TCE and β-adrenergic blockers, 
the investigation is almost nil. Therefore, an attempt was made to 
evaluate the combined effect of TCE with AT and PP if any, in the ISO-
induced myocardial damage that is known to induce myocardial necrosis 
and cardiotoxicity [6-8]. 
MATERIALS AND METHODS  
Standardized methanolic leaves extract of 
Chemicals 
Tinospora cordifolia was 
obtained from Sami Labs Limited, Peenya Industrial Area, Bangalore, 
Karnataka 560058 as gift samples. Isoproterenol hydrochloride was 
purchased from TCI Chemicals (India) Pvt. Ltd. Tambaram, Chennai, 
Tamilnadu–600045, India. Creatine kinase-MB (CK-MB), creatine 
phosphokinase (CPK), lactate dehydrogenase (LDH), aspartate 
aminotransferase (AST), and alanine aminotransferase (ALT) 
standard kits were purchased from ARKRAY Healthcare Pvt. Ltd. 
Santacruz (East) Mumbai 400055, INDIA. Other chemicals used were 
purchased from SD Fine Chemicals Ltd. (Mumbai, India). All 
chemicals used for the experiment were of analytical grade. 
Experiments were carried out using male Albino Wister rats weighing 
150 to 200g were supplied by Sri Venkateshwara Enterprises, No. 
4304, 13th main, 2nd cross, Subramanyanagar, Bangalore 560021, 
Karnataka, India. They were housed in polypropylene cages (47 cm 
x34 m x20 cm) lined with husk, renewed every 24 h under a 12:12 h 
light-dark cycle. The animals had free access to water and food, 
Experimental animals 
ad 
libitum. The animals were fed on a standard pellet diet. The 
experiment was carried out according to the guidelines of the 
Committee for the Purpose of Control and Supervision of Experiments 
on Animals (CPCSEA), New Delhi, India, and approved by the Animal 
Ethical Committee of SET’s College of Pharmacy (Reg. No. 
112/PO/ReS/1999/CPCSEA, Ref No. SET/CP/IAEC/487/1 dated 
7/02/2017) S. R. Nagar, Dharwad, Karnataka, India.  
TCE, AT, PP were dissolved in distilled water for oral 
administrations to the rats. The doses for TCE 250 mg/kg and 500 
mg/kg [9], AT 10 mg/kg [10], PP 10 mg/kg [11] were selected on the 
basis of previous studies. Similarly, previous experiments for dose-
finding indicate ISO 85 mg/kg injected subcutaneously [12] twice at 
an interval of 24 h induces cardiac tissue necrosis in the rats and 
significant changes in biochemical parameters; therefore, 85 mg/kg 
was selected. 
Preparation and dose selection of TCE, AT, PP and ISO 
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The rats were divided into 10 groups of 6 animals each. Group I 
termed as the control group, received distilled water at 1 ml/kg p. o 
daily for 21 d; Group II termed as ISO control, received two 
injections of ISO at 85 mg/kg, s. c at 24 h of interval on 20th and 21st 
days; Group III termed as TCE250, received TCE at 250 mg/kg p. o 
daily for 21 d and ISO (85 mg/kg s. c) on 20th and 21st days at 24 h 
of interval; Group IV termed as TCE500, received TCE at 500 mg/kg 
p. o daily for 21 d and ISO (85 mg/kg s. c) on 20th and 21st days at 
24 h of interval; Group V termed as AT10, received Atenolol (AT) at 
10 mg/kg p. o daily for 21 d and ISO (85 mg/kg s. c) on 20th and 
21st days at 24 h of interval; Group VI termed as PP10, received 
Propranolol (PP) at 10 mg/kg p. o daily for 21 d and ISO (85 mg/kg 
s. c) on 20th and 21st days at an 24 h of interval; Group VII termed 
as TCE250+AT10, received TCE at 250 mg/kg p. o and AT at 10 
mg/kg p. o daily for 21 d and ISO (85 mg/kg s. c) on 20th and 21st 
days at 24 h of interval; Group VIII termed as TCE500+AT10, 
received TCE at 500 mg/kg p. o and AT at 10 mg/kg p. o daily for 21 
d and ISO (85 mg/kg s. c) on 20th and 21st days at 24 h of interval; 
Group IX termed as TCE250+PP10, received TCE at 250 mg/kg p. o 
and PP at 10 mg/kg p. o daily for 21 d and ISO (85 mg/kg s. c) on 
20th and 21st days at 24 h of interval; Group X termed as 
TCE500+PP10, received TCE at 500 mg/kg p. o and PP at 10 mg/kg 
p. o daily for 21 d and ISO (85 mg/kg s. c) on 20th and 21st days at 
24 h of interval [12].  
Experimental design 
24 h after final ISO injection, blood was withdrawn under light ether 
anesthesia by cardiac puncture and kept aside for 30 min to clot at 
room temperature. The serum was separated by centrifugation at 
3000 rpm at 30 °C for 15 min and used for the estimation of marker 
enzymes viz., CK-MB, AST, LDH, ALT, and CPK. Animals were sacrificed 
by cervical dislocation and hearts were isolated immediately, washed 
with normal saline, and one half was used to prepare 10% (w/v) 
homogenates in phosphate buffer. The homogenates were centrifuged 
at 7000 rpm for 10 min at 4 °C and the supernatants were used for the 
assays of superoxide dismutase (SOD) [13], catalase (CAT) [14], 
glutathione (GSH) [15]. The remaining half was fixed in 10% (w/v) 
buffered formalin and sent for histological studies. 
All the experimental results were expressed as mean±SEM. One-way 
ANOVA followed by Tukey’s test using GraphPad InStat, version 5.0. 
The intergroup difference was considered significant when p<0.05. 
Statistical analysis  
RESULTS 
Effect of standardized extract of Tinospora cordifolia, Atenolol and 
Propranolol on ECG pattern and haemodynamic changes 
 
Table 1: Effect of standardized extract of Tinospora cordifolia, atenolol and propranolol on ECG pattern and haemodynamic changes 
Groups MAB (mmHg) R-amplitude (mV) ST-segment (mV) Heart rate (bpm) 
Normal control 91.43±3.311 0.8351±0.128 0.1789±0.117 313.8±4.128 
Isoproterenol 48.13±2.577### 0.4119±0.081### 0.3429±0.038### 412.7±5.223### 
TCE250 64.25±2.492* 0.5912±0.071* 0.2814±0.065* 376.9±2.088* 
TCE500 68.38±5.712** 0.6631±0.044** 0.2519±0.023** 369.2±3.721** 
AT10 62.83±3.212* 0.5824±0.039* 0.2951±0.058* 378.3±2.415* 
PP10 61.71±4.429* 0.5933±0.022* 0.2868±0.047* 377.2±3.329* 
TCE 250+AT 10 67.09±4.221** 0.6529±0.089** 0.2443±0.054** 365.4±4.491** 
TCE 500+AT 10 74.18±3.412*** 0.6909±0.067*** 0.2193±0.031*** 348.6±5.231*** 
TCE 250+PP 10 68.92±2.349** 0.6604±0.058** 0.2492±0.017** 364.2±4.092** 
TCE 500+PP 10 74.8±2.581*** 0.6875±0.092*** 0.2234±0.020*** 356.4±4.178*** 
The values are expressed as mean±SEM (n=6) *P<0.05, **P<0.01, ***P<0.001 as compared to ISO treated group. #P<0.05,##P<0.01, ###
 
P<0.001 values 
compared to control groups.  
Table 1 shows the effect of TCE, AT, PP, and the effect of their 
combination 
 
on haemodynamic changes and ECG pattern. ISO-treated 
animals showed significant alterations in the ECG pattern when 
compared to normal rats. An increased ST-segment and decrease in R-
amplitude was seen in ISO-administered rats when compared to 
normal rats, which confirms MI in rats. ISO treated control group 
animals showed a significant (p<0.001) increase in heart rate and 
decrease MAB compared to normal rats animals. Pre-treatment with 
TCE 500 mg/kg+AT 10 mg/kg and TCE 500 mg/kg+PP 10 mg/kg 
showed significant (p<0.001) in decrease in ST-segment and 
significant (p<0.001) increase in R-amplitude, also significant 
(p<0.001) reduction in HR and MAB when compared to ISO treated 
rats. Whereas animals treated with TCE 500 mg/kg, TCE 250 mg/kg+ 
AT 10 mg/kg, and TCE 250 mg/kg+PP 10 mg/kg showed a significant 
(P<0.01) decrease in ST-segment and a marked (P<0.01) increase in 
the R-amplitude as compared to ECGs from ISO treated animals. 
Animals treated with TCE 500 mg/kg, TCE 250 mg/kg+AT 10 mg/kg 
and TCE 250 mg/kg+PP 10 mg/kg showed significant (P<0.01) 
decrease in HR and increase MAB compared to ISO treated rats. 
Further, rats treated with TCE 250 mg/kg, AT 10 mg/kg, and PP 10 
mg/kg showed significant (P<0.05) reduction in ST-segment, elevation 
in R-amplitude when compared to ECGs from ISO control rats. 
Table 2: Effect of standardized extract of Tinospora cordifolia, atenolol and propranolol on cardiac biomarker enzymes 
Groups CKMB(IU/l) CPK(IU/l) LDH(IU/l) AST/SGOT (IU/l) ALT/SGP (IU/l) 
Normal control 392.3±11.022 168.3±3.149 352.4±4.221 31.58±2.019 73.19±4.639 
Isoproterenol 689.5±10.214### 443.3±6.218### 689.3±6.343### 82.41±3.123### 191.33±5.543### 
TCE250 510.7±10.813* 264.3±7.658* 458.4±241* 62.71±3.448* 139.69±6.671* 
TCE500 483.8±9.449** 233.4±5.119** 431.2±8.170** 56.71±5.354** 121.43±4.268** 
AT10 516.2±10.678* 269.3±4.471* 461.2±5.338* 63.20±4.181* 141.40±3.488* 
PP10 521.3±9.924* 272.9±7.258* 463.9±3.512* 64.49±3.231* 142.91±6.519* 
TCE 250+AT 10 465.2±10.335** 248.3±4.329** 425.9±10.521** 54.73±4.422** 115.40±5.371** 
TCE 500+AT 10 438.8±8.336*** 228.4±5.319*** 408.4±7.492*** 48.29±2.188*** 102.24±4.251*** 
TCE 250+PP 10 471.4±10.567** 251.7±4.369** 429.8±6.401** 55.69±4.551** 117.40±3.721** 
TCE 500+PP 10 441±7.221*** 230.3±4.253*** 413.8±6.581*** 49.53±3.233*** 104.53±3.289*** 
The values are expressed as mean±SEM (n=6) *P<0.05, **P<0.01, ***P<0.001 as compared to ISO treated group. #P<0.05, ##P<0.01, ###P<0.001 
values compared to control groups.  
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Effect of standardized extract of Tinospora cordifolia, atenolol 
and propranolol on heart enzymes 
The effects of TCE, AT, PP, and their combinations on serum cardiac 
marker enzymes such as CKMB, CPK, LDH, AST, and ALT are shown 
in table 2. Rats administered with ISO showed a significant increase 
(p<0.001) in cardiac serum marker enzymes compared with the 
normal control animals. Rats pre-treatment of TCE 500 mg/kg+ AT 
10 mg/kg and TCE 500 mg/kg+PP 10 mg/kg for 21 d, in addition, 
ISO subcutaneously administered on the 20th and 21st days, 
produced a significant (p<0.001) decreased in the ISO-induced 
elevated levels of CKMB, CPK, LDH, AST, and ALT. Whereas animals 
treated with TCE 500 mg/kg, TCE 250 mg/kg+AT 10 mg/kg and TCE 
250 mg/kg+PP 10 mg/kg showed significant (P<0.01) decrease in 
heart marker enzymes. Further, animals administered treated with 
TCE 250 mg/kg, AT 10 mg/kg, and PP 10 mg/kg showed a 
significant (P<0.05) decrease in cardiac enzymes compared to 
normal control animals. The combination treatments 
(TCE500+AT10 and TCE500+PP10) were significantly better than 
TCE, AT, PP alone treatment in reducing ISO elevated serum enzyme. 
 
 
Fig. 1: Effect of Tinospora cordifolia, atenolol and propranolol on heart antioxidant enzymes 
 
Effect of standardized extract of Tinospora cordifolia, Atenolol 
and Propranolol on heart antioxidants 
Effect of different TCE, AT, PP, and their combinations on heart 
antioxidant parameters like SOD, CAT, and GSH were depicted in fig. 1. 
ISO treated rats shown a significant decrease (P<0.001) in heart 
antioxidants compared to normal control rats. SOD, CAT and GSH 
levels were significantly (P<0.001) increased in TCE 500 mg/kg+AT 10 
mg/kg and TCE 500 mg/kg+PP 10 mg/kg administered animals when 
compared to ISO treated animals. Treatment of TCE 500 mg/kg, TCE 
250 mg/kg+AT 10 mg/kg and TCE 250 mg/kg+PP 10 mg/kg showed 
significant (P<0.01) elevation in antioxidants. Whereas animals 
treated with TCE 250 mg/kg, AT 10 mg/kg, and PP 10 mg/kg showed 
significant (P<0.05) increase in heart antioxidants. 
 
 
Fig. 2: Histopathological observations in rat cardiac tissue A) Normal control, B) ISO control, C) TCE 250, D) TCE 500 E) AT 10, F) PP 10 G) 
TCE 250+AT 10 H) TCE 500+AT 10 I) TCE 250+PP 10 J) TCE 500+PP 10 
 
Histopathology study 
Histopathological observations of the cardiac tissue (fig. 2) from 
normal rats (A) showed a normal arrangement of the myocardial cell 
membrane. No inflammatory cells were observed. (B) Heart tissue of 
ISO administered animals revealed congestion and necrosis in 
cardiac cells with the entry of inflammatory cells and also 
pathological abnormalities along the endocardium. The heart tissue 
from animals treated with (C) TCE (250 mg/kg), (D) TCE 500, (E) AT 
(10 mg/kg) and (F) PP (10 mg/kg) showed mild protection against 
ISO-induced cardiac damage. Animals treated with (G) TCE (250 
mg/kg)+AT (10 mg/kg), (H) TCE (500 mg/kg)+AT (10 mg/kg), (I) 
TCE (250 mg/kg)+PP (10 mg/kg) and (J) TCE 500 (mg/kg)+PP (10 
Savant et al. 
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mg/kg) showed minimal-to-mild cardiac cell abnormalities with 
minimal diffuse of lymphocytic cells along the endocardium.  
DISCUSSION 
In the present study, MI was produced by treating rats with ISO 
subcutaneously at a dose of 85 mg/kg for two consecutive days. It 
has been observed that treatment with ISO at high doses to rats 
induces ‘infarct-like’ changes in the cardiac tissue similar to in MI 
patients in humans [16]. The production of free radicals increases 
lipid peroxides and membrane permeability changes which leads to 
loss of normal integrity of myocardial membranes. All the large 
molecules to leak from injured tissues and because of their tissue 
specificity are the markers of cardiac tissue injury [17, 18].  
The leakage of CK-MB, CPK, LDH, AST, and ALT from the injured 
cardiac cells into serum confirms the ISO-induced cardiac necrosis. 
Other evidence of the cardiac toxic effect of ISO is the 
histopathological alterations in the heart tissue along with abnormal 
changes in ECG pattern, especially increased ST-segment and 
reduction in R-amplitude indicate standard measure used to 
diagnose MI in humans and animals [19]. 
The combination of TCE (500 mg/kg)+AT (10 mg/kg) and TCE (500 
mg/kg)+PP (10 mg/kg) 
Antioxidants are the first-line defense that limits the injury-related 
to free radicals [19]. Reduction in the levels of SOD, CAT, and GSH 
was seen in ISO-treated animals. Decreased levels of GSH may be due 
to its enhanced usage during the free radical production in 
protecting the ‘SH’ group containing proteins from LPO [21]. 
preserved the structural and functional 
integrity of the cardiac cell membrane as evident from the reduction 
in the increased levels of serum cardiac markers and improvement 
in the ECG of rats pre-treated with the combinations when 
compared to the individual treatment groups, thereby indicating the 
cardioprotective effect of the combination of TCE (500 mg/kg)+AT 
(10 mg/kg) and TCE (500 mg/kg)+PP (10 mg/kg). 
Plants containing polyphenols have many pharmacological effects. 
These polyphenols are secondary metabolites in which functional 
groups bound to the aromatic ring; hence, they act as donors of 
electron and hydrogen atom to stop radical chain reaction by forming 
stable products of free radicals. Flavonoids, tannins, and lignins are the 
major components of polyphenols. The pharmacological effects of 
these polyphenols are mainly due to the antioxidant property in 
scavenging free radicals [22]. The present study results correspond 
with the earlier results indicating that Tinospora cordifolia
Atenolol and Propranolol are selective β receptor antagonists that 
are used for the treatment of cardiovascular disease like, high blood 
pressure, coronary heart diseases, arrhythmias, angina pectoris and 
also reduce the risk of heart complications following MI [24, 25]. 
 has a potent 
antioxidant property with high total phenolic and total flavonoid 
content in the methanolic extract [23]. 
Hence, pre-co-treatment with the combination of TCE (500 
mg/kg)+AT (10 mg/kg) and TCE (500 mg/kg)+PP (10 mg/kg) 
significantly prevented the changes in the levels of serum cardiac 
markers like CK-MB, CPK, LDH, AST, and ALT. Further antioxidants 
such as SOD, CAT, and GSH and restored the levels to near normalcy 
when compared to individual groups. This effect may be due to the 
free radical scavenging activities of TCE. The histopathological 
report revealed significant protection against ISO-induced heart 
tissue necrosis in the rats treated with combinations. 
CONCLUSION 
From the present study, it may be concluded that the herb-drug 
combinations i. e TCE (500 mg/kg)+AT (10 mg/kg) and TCE (500 
mg/kg)+PP (10 mg/kg) have shown increased cardioprotective activity 
than they were used alone. However, further dose adjustment and 
molecular mechanism study need to perform for better understanding. 
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